C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire 51% stake in TDS Corporation from Tadashi Tsuji on August 30, 2022. TDS Corporation Fiscal year ending May 2022 sales volume is ¥540 million yen, Total Assets ¥288 million, Operating Income ¥28 million, and Net Income ¥33 million. Stock transfer execution date September 5, 2022 (planned).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
898 JPY | -2.07% |
|
-2.50% | +6.90% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.90% | 279M | |
+9.92% | 27.7B | |
+25.93% | 2.46B | |
+18.11% | 2.46B | |
-49.80% | 2.24B | |
+32.22% | 2.02B | |
-31.22% | 2.06B | |
-21.57% | 1.65B | |
+9.03% | 1.36B | |
+32.97% | 1.33B |
- Stock Market
- Equities
- 3540 Stock
- News C.I. Medical Co.,Ltd.
- C.I. Medical Co.,Ltd. agreed to acquire 51% stake in TDS Corporation from Tadashi Tsuji.